PR Newswire, November 22, 2016. Experts from opposite ends of the ideological spectrum were united over concern about the 21st Century Cures Act at an emergency briefing in the U.S. Senate yesterday. While highlighting different problems, they agreed that Congress should not rush a closed-door negotiated version of the bill during the lame-duck session.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Law Firm that Believes FDA is ‘Broken’ Highlights Cures Act Fears
Fierce Biotech, November 23, 2016. We know it’s a top priority for Congress, but a group of panelists speaking at an “emergency briefing” in the U.S. Senate this week hosted by an anti-FDA legal co have urged lawmakers to not “rush a closed-door negotiated version of the bill during the lame-duck session.”
Read More »Congress Shouldn’t Pass FDA Reform Bills Without Addressing Patient Safety and Drug Prices
The Health Care Blog, November 23, 2016. Find out why NCHR president is worried about the 21st Century Cures Act and cautions strongly against its hasty passage in lame-duck session.
Read More »Actress Elisabeth Rohm Urges You to Give Back and Join the Fight Against Cancer!
November 23, 2016. Actress Elisabeth Rohm urges you to join us and fight cancer in her new public service announcement.
Read More »This Tiny Plastic Implant May Disrupt America’s Opioid Addiction Problem
Motherboard by Vice, November 15, 2016. “I think the big issue is the transition,” said Diana Zuckerman, NCHR President, who was not involved with the trials. “People are going to go from taking pills to using this implant. The implant doesn’t work immediately. It takes a while for it to work and settle into the level that it’s supposed to be. And during that time the person is still going to be taking pills, and that becomes a vulnerable time. How many pills should that person take before the implant is really working, and should they continue to take pills after it’s working?“
Read More »